• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Abiomed

Federal court revives Getinge heart pump patent suit against J&J’s Abiomed

March 24, 2025 By Sean Whooley

The U.S. Court of Appeals for the Federal Circuit has brought back a patent infringement case between Getinge’s Maquet and Johnson & Johnson’s Abiomed. This lawsuit dates back to 2016, when heart pump maker Abiomed, now a Johnson & Johnson MedTech unit, sued Getinge’s Maquet for a judgment of non-infringement of a trio of patents. Counter-suits later […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Legal News, Patent Infringement, Structural Heart Tagged With: Abiomed, Getinge, Johnson & Johnson, Johnson & Johnson MedTech, Maquet, Maquet Cardiovascular LLC

J&J’s Abiomed updates Impella RP instructions in Class I recall

February 14, 2025 By Sean Whooley

The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson MedTech Abiomed Impella RP heart pump. Impella RP offers up to 14 days of use in patients who develop acute right heart failure after left ventricular assist device (LVAD) implantation. Placed in the internal jugular vein, it supports the […]

Filed Under: Cardiac Implants, Cardiovascular, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Structural Heart Tagged With: Abiomed, FDA, Johnson & Johnson, Johnson & Johnson MedTech

The biggest cardiovascular tech stories from TCT 2024

November 1, 2024 By Sean Whooley

The 2024 edition of the Transcatheter Cardiovascular Therapeutics (TCT) conference once again highlighted significant innovations in cardiovascular care. This year’s event in Washington, D.C., featured company updates on all types of technologies, including heart valves, access and closure devices, drug-eluting implants, intravascular lithotripsy (IVL), renal denervation (RDN) and more. Some of the biggest names in […]

Filed Under: Artificial Intelligence (AI), Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Drug-Eluting Stents, Featured, Health Technology, Implants, Machine Learning (ML), Replacement Heart Valves, Software / IT, Stents, Structural Heart Tagged With: Abiomed, Boston Scientific, cardiawave, Edwards Lifesciences, Elixir Medical, HeartFlow, Inari Medical, Johnson & Johnson, Johnson & Johnson MedTech, Medtronic, MitrAssist Medical, nitinol, Shockwave Medical, TCT 2024, Vivasure Medical

Johnson & Johnson has positive Impella ECP heart pump data

October 28, 2024 By Sean Whooley

Johnson & Johnson MedTech reported positive data for the Abiomed Impella ECP transvalvular axial flow pump with compressible pump architecture. Investigators presented results at Transcatheter Cardiovascular Therapeutics (TCT) 2024 in Washington, D.C. Dr. Amir Kaki led the FDA IDE study — the first completed pivotal trial for Impella ECP — as principal investigator. J&J said […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Implants, Structural Heart Tagged With: Abiomed, Johnson & Johnson, Johnson & Johnson MedTech, TCT 2024

Abiomed reports positive Impella CP results in treating cardiogenic shock

April 8, 2024 By Sean Whooley

Johnson & Johnson’s Abiomed shared data supporting the use of its Impella CP in patients who had a heart attack with cardiogenic shock. The data was presented at the American College of Cardiology conference and published it in the New England Journal of Medicine. The study evaluated patients who had a heart attack with ST-elevation […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Structural Heart Tagged With: Abiomed, Johnson & Johnson, Johnson & Johnson MedTech

J&J’s Abiomed has a Class I Impella labeling recall with 49 deaths related to issue

March 21, 2024 By Sean Whooley

The FDA deemed a recall of heart pumps from Johnson & Johnson MedTech’s (NYSE:JNJ) Abiomed Class I, the most serious kind. Abiomed reports 129 serious injuries, including 49 deaths, related to the issue of potential cuts in the wall of the heart. This recall (a correction and not a product removal) affects 66,390 Impella pumps […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Structural Heart Tagged With: Abiomed, FDA, Johnson & Johnson, Johnson & Johnson MedTech

FDA issues warning letter to J&J’s Abiomed over Impella heart pump problems

October 12, 2023 By Jim Hammerand

Abiomed, a Johnson & Johnson unit, has received an FDA warning letter related to its Class I recall of Impella heart pumps. The agency wrote Abiomed up for failing to report problems with the heart pump and selling its Impella Connect System software and hardware without FDA authorization. The FDA issued the letter in September after inspecting […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Featured, Food & Drug Administration (FDA), Implants, News Well, Recalls, Regulatory/Compliance, Structural Heart Tagged With: Abiomed, FDA, Johnson & Johnson, Johnson & Johnson MedTech

FDA deems latest Abiomed Impella recall Class I

August 18, 2023 By Sean Whooley

Abiomed, a Johnson & Johnson unit, issued another recall for some of its Impella heart pumps. This marks the third safety notice regarding the heart pumps in as many months.  In June, the company recalled 466 Impella 5.5 with SmartAssist devices. Abiomed initiated that recall after receiving complaints relating to purge fluid leaking from the purge […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Featured, Food & Drug Administration (FDA), Implants, Recalls, Regulatory/Compliance, Structural Heart Tagged With: Abiomed, Johnson & Johnson, Johnson & Johnson MedTech

J&J’s Abiomed recalls Impella again — this time it’s TAVR-related

July 20, 2023 By Sean Whooley

Johnson & Johnson’s Abiomed unit issued another recall for some of its Impella heart pumps. FDA communications dated July 14 confirmed the second recall in a month for certain Impella products. In June, the company recalled 466 Impella 5.5 with SmartAssist devices. Abiomed initiated that recall after receiving complaints relating to purge fluid leaking from […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Implants, News Well, Recalls, Regulatory/Compliance, Replacement Heart Valves, Stents, Structural Heart Tagged With: Abiomed, Johnson & Johnson, Johnson & Johnson MedTech, tavr

Abiomed recalls some Impella 5.5 with SmartAssist devices

June 5, 2023 By Sean Whooley

The FDA today issued a field safety notice deeming a recall of Abiomed Impella 5.5 heart pumps as Class I, the most serious kind. Abiomed — bought by Johnson & Johnson for $16.6 billion last year — recalled 466 affected devices. It distributed these Impella 5.5 with SmartAssist devices between Sept. 28, 2021, and March […]

Filed Under: Cardiac Implants, Cardiovascular, Food & Drug Administration (FDA), Implants, Recalls, Regulatory/Compliance, Structural Heart Tagged With: Abiomed, FDA, Johnson & Johnson

The top 10 cardiac device stories of 2022

December 22, 2022 By Chris Newmarker

From pulsed-field ablation to noninvasive monitoring, this was an exciting year for cardiac device tech. Here are the top 10 cardiac device stories from MassDevice and its sister sites: 10. Medtronic to pay Acutus $17M following EU MDR submission of left-heart access portfolio Earlier this year, Acutus agreed to sell its left-heart access portfolio to […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Catheters, Pulsed-Field Ablation (PFA), Replacement Heart Valves, Stents, Structural Heart Tagged With: Abbott, Abiomed, Acutus Medical, Affera, Boston Scientific, Cordis, Edwards Lifesciences, iRhythm Technologies, Johnson & Johnson, Johnson & Johnson MedTech, MedAlliance, Medtronic

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 31
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy